Comparison between Concord Biotech IPO and Yatharth Hospital IPO.
Concord Biotech IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Yatharth Hospital IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Concord Biotech IPO is up to ₹1,550.52 Cr whereas the issue size of the Yatharth Hospital IPO is up to ₹686.55 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Yatharth Hospital IPO is ₹300.00 per share.
| Concord Biotech IPO | Yatharth Hospital IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹705.00 per share | ₹285.00 per share |
| Issue Price (Upper) | ₹741.00 per share | ₹300.00 per share |
| Issue Price (Final) | ₹741.00 per share | ₹300.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ₹70.00 per share | |
| Market Lot Size | 20 shares | 50 shares |
| Fresh Issue Size | 0 shares | 1,63,33,333 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹490.00 Cr |
| OFS Issue Size | 2,09,25,652 shares | 65,51,690 shares |
| OFS Issue Size (Amount) | up to ₹1,550.52 Cr | up to ₹196.55 Cr |
| Issue Size Total | 2,09,25,652 shares | 2,28,85,023 shares |
| Issue Size Total (Amount) | up to ₹1,550.52 Cr | up to ₹686.55 Cr |
Concord Biotech IPO opens on Aug 04, 2023, while Yatharth Hospital IPO opens on Jul 26, 2023. The closing date of Concord Biotech IPO and Yatharth Hospital IPO is Aug 08, 2023, and Jul 28, 2023, respectively.
| Concord Biotech IPO | Yatharth Hospital IPO | |
|---|---|---|
| Anchor Bid Date | Aug 03, 2023 | Jul 25, 2023 |
| Issue Open | Aug 04, 2023 | Jul 26, 2023 |
| Issue Close | Aug 08, 2023 | Jul 28, 2023 |
| Basis Of Allotment (Tentative) | Aug 11, 2023 | Aug 02, 2023 |
| Initiation of Refunds (Tentative) | Aug 14, 2023 | Aug 03, 2023 |
| Credit of Share (Tentative) | Aug 17, 2023 | Aug 04, 2023 |
| Listing date (Tentative) | Aug 18, 2023 | Aug 07, 2023 |
| Anchor Lockin End date 1 | Sep 10, 2023 | Sep 01, 2023 |
| Anchor Lockin End date 2 | Nov 09, 2023 | Oct 31, 2023 |
Concord Biotech IPO P/E ratio is 32.29, as compared to Yatharth Hospital IPO P/E ratio of 39.16.
| Concord Biotech IPO | Yatharth Hospital IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)
| Company Financials (Restated Consolidated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 44.08 | 91.34 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 44.08 | 66.32 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 32.29 | 39.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7752.06 Cr. | ₹2575.51 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.06% | 35.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.27% | 26.10% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.44 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹20.79 | ₹10.09 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20% | 35.95% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Concord Biotech IPO Retail Individual Investors (RII) are offered 73,20,479 shares while in Yatharth Hospital IPO retail investors are offered 73,20,479 shares. Qualified Institutional Buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 45,77,004 shares in Yatharth Hospital IPO.
| Concord Biotech IPO | Yatharth Hospital IPO | |
|---|---|---|
| Anchor Investor Reservation | 62,74,695 shares | 68,65,506 shares |
| Market Maker Reservation | ||
| QIB | 41,83,130 shares | 45,77,004 shares |
| NII | 31,37,348 shares | 34,32,754 shares |
| RII | 73,20,479 shares | 80,09,759 shares |
| Employee | 10,000 shares | |
| Others | ||
| Total | 2,09,25,652 shares | 2,28,85,023 shares |
Concord Biotech IPO subscribed 24.87x in total, whereas Yatharth Hospital IPO subscribed 37.28x.
| Concord Biotech IPO | Yatharth Hospital IPO | |
|---|---|---|
| QIB (times) | 67.67x | 86.37x |
| NII (times) | 16.99x | 38.62x |
| Big NII (times) | 19.30x | 41.76x |
| Small NII (times) | 12.37x | 32.34x |
| RII (times) | 3.78x | 8.66x |
| Employee (times) | 24.48x | |
| Other (times) | ||
| Total (times) | 24.87x | 37.28x |
